Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study
- PMID: 17942810
- DOI: 10.2967/jnumed.107.043471
Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study
Abstract
Nicotinic acetylcholine receptors (nAChRs) are of great interest because they are implicated in various brain functions. They also are thought to play an important role in nicotine addiction of smokers. Chronic (-)-nicotine, a nAChR agonist, treatment in mice and rats elicits a dose-dependent increase in nAChRs in the brain. Upregulation of nAChRs in postmortem human brains of smokers has also been reported. However, changes in nAChRs after cigarette smoking cessation in humans are poorly understood. The aim of this study was to detect the dynamic changes of nAChRs after smoking and smoking cessation in the brains of living subjects.
Methods: We performed 5-(123)I-iodo-A-85380 ((123)I-5IA) SPECT on nonsmokers and smokers (n = 16) who had quit smoking for 4 h, 10 d, and 21 d and calculated and compared distribution volumes (Vt) of (123)I-5IA.
Results: The binding potential of nAChRs (Vt of (123)I-5IA) in the brains of smokers decreased by 33.5% +/- 10.5% after 4 h of smoking cessation, increased by 25.7% +/- 9.2% after 10 d of smoking cessation, and decreased to the level of nonsmokers after 21 d of smoking cessation.
Conclusion: Because the upregulation of the nAChRs of the smokers after chronic exposure of the nicotine was downregulated to the nonsmokers' level by around 21 d after smoking cessation, the upregulation is a temporary effect. The decrease in nicotinic receptors to nonsmoker levels may be the breaking point during the nicotine withdrawal period.
Similar articles
-
Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.Nucl Med Biol. 2016 Jun;43(6):372-8. doi: 10.1016/j.nucmedbio.2016.02.007. Epub 2016 Mar 3. Nucl Med Biol. 2016. PMID: 27260778
-
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers.Arch Gen Psychiatry. 2012 Apr;69(4):418-27. doi: 10.1001/archgenpsychiatry.2011.1465. Arch Gen Psychiatry. 2012. PMID: 22474108 Free PMC article.
-
Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.J Nucl Med. 2004 Sep;45(9):1458-70. J Nucl Med. 2004. PMID: 15347712 Clinical Trial.
-
Nicotine addiction: the possible role of functional upregulation.Trends Pharmacol Sci. 2002 Mar;23(3):130-6. doi: 10.1016/S0165-6147(00)01979-9. Trends Pharmacol Sci. 2002. PMID: 11879680 Review.
-
Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies.J Clin Pharm Ther. 2014 Oct;39(5):457-67. doi: 10.1111/jcpt.12171. Epub 2014 May 14. J Clin Pharm Ther. 2014. PMID: 24828779 Free PMC article. Review.
Cited by
-
Cholinergic system adaptations are associated with cognitive function in people recently abstinent from smoking: a (-)-[18F]flubatine PET study.Neuropsychopharmacology. 2023 Mar;48(4):683-689. doi: 10.1038/s41386-023-01535-1. Epub 2023 Jan 21. Neuropsychopharmacology. 2023. PMID: 36681758 Free PMC article.
-
A positive relationship between harm avoidance and brain nicotinic acetylcholine receptor availability.Psychiatry Res. 2013 Dec 30;214(3):415-21. doi: 10.1016/j.pscychresns.2013.07.010. Epub 2013 Oct 19. Psychiatry Res. 2013. PMID: 24148908 Free PMC article.
-
Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.AAPS J. 2009 Mar;11(1):167-77. doi: 10.1208/s12248-009-9090-7. Epub 2009 Mar 12. AAPS J. 2009. PMID: 19280351 Free PMC article. Review.
-
Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use.Genes Brain Behav. 2016 Jan;15(1):89-107. doi: 10.1111/gbb.12251. Epub 2015 Dec 23. Genes Brain Behav. 2016. PMID: 26351737 Free PMC article. Review.
-
Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence.Psychiatry Res. 2010 Sep 30;183(3):218-24. doi: 10.1016/j.pscychresns.2009.06.004. Epub 2010 Aug 3. Psychiatry Res. 2010. PMID: 20682457 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical